PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Health & social (CPV 85)›
  4. Exact Sciences UK, Ltd.
ES

Exact Sciences UK, Ltd.

Health & social · London
SME

Exact Sciences UK, Ltd. specializes in cancer prevention, screening, and therapy guidance through innovative testing solutions. They aim to transform cancer detection and management for patients worldwide.

exactsciences.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£3.3m
Live
19
Buyers
20
12m
£311k
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities1
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts19 / 26
  • Top buyers20
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Exact Sciences UK, Ltd.Updated 13 Jul 2026

At a glance · for buyers and watchdogs

Exact Sciences UK, Ltd. has won £3.3m across 20 public-sector buyers, with 19 live contracts. No active Companies House risk flags.

Why: top buyer Norfolk and Norwich University Hospitals NHS Foundation Trust at 19% · 75% in Health & social · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
19 of 26Live contracts
19%Top-buyer concentration
75%Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 5
Cancerguard® testAn innovative multi-cancer early detection test. ↗Cologuard® testA stool test for colorectal cancer screening. ↗Oncodetect® testA circulating tumor DNA test for cancer detection. ↗Oncoguard® Liver testA blood test for liver cancer detection. ↗Oncotype DX testsTests for breast and colon cancer recurrence scores. ↗
Frameworks & DPS · 1 from notices
  • Exact Sciences - Oncotype DX Breast Recurrence Score testsNorfolk and Norwich University Hospitals NHS Foundation Trust · £158k

Extracted automatically from exactsciences.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 19 live · 7 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Oncotype DX Breast Cancer Testing
East Sussex Healthcare NHS Trust8511180001 Apr 2026£136k12 moLive
Exact Sciences - Oncotype DX Breast Recurrence Score tests
Norfolk and Norwich University Hospitals NHS Foundation Trust8512120027 Feb 2026£158k13 moLive
Oncotype DX Breast recurrence score test
Leeds Teaching Hospitals NHS Trust3369620001 Jul 2025£96k12 moClosed
Purchase of Oncotype DX Tests
Gateshead Health NHS Foundation Trust3369800001 Apr 2025£392k2 yrsLive
BTH25-027 Oncotype DX Breast Recurrence Score test
Bradford Teaching Hospitals NHS Foundation Trust3369650001 Apr 2025£97k3 yrsLive
SUPPLY OF ONCOTYPE DX BREAST RECURRENCE SCORE TEST
HULL ROYAL INFIRMARY8511180012 Mar 2024£304k3 yrsLive
Breast Cancer Oncotype Testing
Lincolnshire Partnership NHS Foundation8511180012 Mar 2024£245k3 yrsLive
Screening Services
The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust8511180001 Apr 2024£190k3 yrsLive
Oncotype DX Test
East Suffolk & North Essex NHS FT8511181001 Apr 2024£287k3 yrsLive
Oncotype DX testing
SOMERSET NHS FOUNDATION TRUST8511180012 Mar 2024£101k12 moClosed
Total live value £2.3m · mean award £126k1–10 of 26

Top buyers · 20 buyers · top 3 = 42%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
Norfolk and Norwich University Hospitals NHS Foundation Trust
3 contracts
19%
since 2024
2
Gateshead Health NHS Foundation Trust
1 contract
12%
since 2025
3
ST HELENS & KNOWSLEY TEACHING HOSPITALS NHS TRUST
1 contract
11%
since 2022
4
HULL ROYAL INFIRMARY
1 contract
9%
since 2024
5
East Suffolk & North Essex NHS FT
1 contract
9%
since 2024
6
The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust
2 contracts
8%
since 2021
7
Lincolnshire Partnership NHS Foundation
1 contract
8%
since 2024
8
Hull University Teaching Hospitals NHS Trust
1 contract
7%
since 2021
9
East Sussex Healthcare NHS Trust
1 contract
4%
since 2026
10
SOMERSET NHS FOUNDATION TRUST
3 contracts
3%
since 2024

Category mix

CPV-division share of last-12m awarded value. Single-category exposure: 75%.

✓ From notices
Health & social85
75%
Medical equipment33
25%
⚠ Concentration: 75% of recent awarded value sits in a single CPV division. A category-specific downturn would materially affect revenue.

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Eastern5 contracts
44%
Yorkshire4 contracts
22%
North East1 contract
19%
South East1 contract
7%
South West5 contracts
5%
North West1 contract
3%
Northern Ireland2 contracts
0%
West Midlands1 contract
0%
Region resolved for 62% of awarded value (by buyer postcode); the remainder lacks a usable address.

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Exact Sciences UK, Ltd. highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
OC
Oracle Corporation UK Limited
No£20.6m1
AT
Atamis Ltd
Yes£18.1m2
PS
Phoenix Software Limited
Yes£6.0m9
RA
Radiometer Limited
Yes£4.9m2
SO
Softcat
Yes£4.3m12
ES
Exact Sciences UK, Ltd.
Yes£311k—
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Due in 18d
Next due 31 Jul 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
07484560
Status
Active
Type
Private limited
Incorporated
06 Jan 2011
Reg. office
Scott House The Concourse, Waterloo Station, London, SE1 7LY
SIC codes
82990
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • SLATER, Bradley Jay — director
    Appointed 25 Mar 2026
  • WENNER, James Russell — director
    Appointed 25 Mar 2026
  • HOTTMANN, Katherine Ava Miller — director
    Appointed 01 Jul 2025
  • ROBERTS, Andrew James — director
    Appointed 01 Apr 2025
  • HERRIOTT, James Michael John — director
    Appointed 30 Jun 2022
  • Exact Sciences Corp. — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
EXACT SCIENCES UK, LTD.
07484560 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.